Science Group Executive Chair Buys 10,000 Shares

Published 07/04/2025, 12:12
Science Group Executive Chair Buys 10,000 Shares

LONDON - Science Group plc (AIM:SAG), a company listed on the AIM segment of the London Stock Exchange (LON:LSEG), disclosed today that its Executive Chair, Martyn Ratcliffe, has purchased 10,000 ordinary shares at a price of 410 pence per share. The transaction took place on Monday and was conducted on the AIM exchange.

Following this acquisition, Ratcliffe’s total interest in Science Group has increased to 9,492,080 ordinary shares, which represents approximately 21.27% of the company’s issued share capital, excluding treasury shares. This stake includes 9,412,080 shares held directly by Ratcliffe and 80,000 shares within his Self-Invested Personal Pension (SIPP).

There have been no changes to the beneficial interests of the other Directors in the share capital of Science Group, and they remain as previously reported.

The purchase by the Executive Chair is considered a noteworthy event as it reflects a significant investment by a key insider in the company’s stock. Insider purchases can sometimes indicate the leadership’s confidence in the company’s future prospects, although this should not be seen as an endorsement of the company’s future performance.

The transaction details, including the price and volume of shares bought, were disclosed in accordance with regulatory requirements for notifications of transactions by persons discharging managerial responsibilities and others closely associated with them.

Science Group provides advisory and product development services across a range of industries, leveraging its scientific and engineering expertise. The company’s shares are traded on the AIM market, which is known for its dynamic and growing companies.

This information is based on a press release statement from Science Group plc.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.